Amneal Pharmaceuticals (NASDAQ:AMRX) reported quarterly earnings of $0.12 per share which missed the analyst consensus estimate of $0.15 by 20 percent. This is a 14.29 percent decrease over earnings of $0.14 per share from the same period last year. The company reported quarterly sales of $730.52 million which beat the analyst consensus estimate of $707.55 million by 3.25 percent. This is a 18.40 percent increase over sales of $616.98 million the same period last year.